Wolters Kluwer (CCH Tagetik)

Yeah.

So CCH reached out, Wolters Kluwer, and said, hey, do you want to do a podcast at the conference? Do you want to come see what we're doing with AI? And so I've been diving into the new AI features that are coming.

I'm looking forward to learning more.

And I'm going to do a live podcast episode It'll be at the CCH Access Theater stage on Monday at 2.50, and we're going to talk about all the new AI stuff that is coming to their products, which is really interesting because we've been waiting for years for this.

Yeah.

And I'm going to talk to Jason Marks.

He's the CEO of Wolters Kluwer Tax and Accounting and Kathy Rowe.

And we're going to do a live episode there and broadcast that here on the show later.

So my name is Christian, Christian Celda.

I'm a VP and general manager for what we call the international segment within the health division of Wolters Kluwer.

I'm in this organization since 18 years now.

And what I've been running is multiple of our businesses and specifically how to internationalize some of our solutions.

As we continue to move stroke care closer and closer to the time of onset, emerging technologies and biomarkers such as GFAP and artificial intelligence may help us improve prehospital stroke diagnosis in patient selection in conducting clinical trials in the ambulance before patients even reach the hospital.

As always, thriving to stay one step ahead of the game, and what better way to do so than by staying alert with Stroke Alert? [outro music] This podcast is produced by Wolters Kluwer and BioMedia Communications and supported by the editorial team of Stroke.

Our Stroke Alert podcast and production staff includes Nastasia Cremens, Aaron Szakacs, Louis Pasha, Erin Kane, Rebecca Sestrong, and Negar Azadgi.

This program is copyright of the American Heart Association 2026.

[chuckles] I thought you were gonna say, which ones are out, which I'm never g- not gonna say.

Um, the ones we have bought are, you know, we've bought Wolters Kluwer, uh, which has a focus on, you know, those areas I just described, actually, you know, medicine, law, accounting.

Uh- You know, we think that is a pretty good business, pretty sticky, and at least if it does start getting disrupted, there's three or four different areas that could be disrupted at different paces.

Um, so that's an example of the type of one that we've bought.

That's a tax intern that doesn't know their 10 key from their elbow, and that is the job we serve as, like, the client-facing person, is to make the business collectively seem, seem smarter than it actually is.

Very often outsourcing gets conflated with offshoring, but did you know that you can even outsource to US-based groups to do, like, month-end closes and tax automation, all that? Uh, CCH Wolters Kluwer actually bought a company that does th- just this, XP Tax, X-P-I-T-A-X.

Not an advertisement.

Imagine taking money, oh, from CCH.

Yeah.

People who already have lots of data, whether that's, uh, someone like, uh, Wolters Kluwer's, right? Or any of the other publications that are out there, uh, you know, they're basing and building their own LLMs based on the repository information that they have because it's an advantage for them.

Yeah.

So I think, you know, there are s- marketing reasons to be transparent when it's to your advantage, but the ones that maybe haven't got that are the ones that are just being, well, we don't know.

He's the chief technology officer at Lumeris, where he integrates technological innovations, clinical processes, and operational excellence into leading value-based care solutions.

And prior to Lumeris, he has held senior technology leadership roles at Wolters Kluwer Health and Cardinal Health.

And he also oversees the efficient deployment of cutting-edge technologies like GenAI to ensure optimal healthcare outcomes and client satisfaction.

At Lumeris, JC has been closely involved in developing TOM, which is the company's AI-powered primary care as a service platform, and we're really excited to discuss this today with him.

I was, you know, managing this RFID business in Cardinal Health.

We were able to grow it through Cardinal Health and sort of give it enterprise scale from startup scale.

Then I joined Wolters Kluwer Health-

Mm